NEW YORK, Sept. 11 -- Affymetrix (Nasdaq: AFFX) of Santa Clara, Calif., said Monday it had licensed technology for low and medium density DNA arrays to reagent-provider Takara Shuzo of Kyoto, Japan.

Under the terms of the license, Takara has been granted a non-exclusive, worldwide, royalty-bearing license allowing them to manufacture, use and sell low and medium density pre-spotted arrays of up to 5,000 spots per slide.

Affymetrix has yet to license its high-density chip technology, preferring to keep that market for itself.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.